Palatin Technologies Inc. (NYSE AMERICAN: PTN)
$1.81
-0.0200 ( -1.09% ) 70.7K
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
Market Data
Open
$1.81
Previous close
$1.83
Volume
70.7K
Market cap
$29.37M
Day range
$1.79 - $1.87
52 week range
$1.43 - $5.65
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 100 | May 28, 2024 |
def | Proxies and info statements | 13 | May 28, 2024 |
8-k | 8K-related | 16 | May 15, 2024 |
10-q | Quarterly Reports | 69 | May 15, 2024 |
4 | Insider transactions | 1 | Apr 11, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
8-k | 8K-related | 17 | Feb 15, 2024 |
10-q | Quarterly Reports | 75 | Feb 14, 2024 |
8-k | 8K-related | 23 | Feb 01, 2024 |
8-k | 8K-related | 15 | Dec 20, 2023 |